Ironwood Pharmaceuticals Inc (IRWD) — Working Capital to Net Assets Ratio
Ironwood Pharmaceuticals Inc (IRWD) has a Working Capital to Net Assets ratio of -44.2% as of March 2026. Working capital of $95.98 Million (current assets of $332.29 Million minus current liabilities of $236.31 Million) is measured against net assets of $-217.14 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Ironwood Pharmaceuticals Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Ironwood Pharmaceuticals Inc Working Capital to Net Assets (2007–2025)
This chart shows how Ironwood Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2007 to 2025. As of March 2026, the ratio stands at -44.2%, reflecting working capital of $95.98 Million against net assets of $-217.14 Million USD. See how many days can Ironwood Pharmaceuticals Inc fund operations to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Ironwood Pharmaceuticals Inc (2007–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Ironwood Pharmaceuticals Inc from 2007 to 2025, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Ironwood Pharmaceuticals Inc market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -12.2% | $31.96 Million | $-261.83 Million | $274.18 Million | $242.22 Million | ▲ +35.4 pp |
| 2024 | -47.6% | $143.52 Million | $-301.33 Million | $182.37 Million | $38.85 Million | ▼ -60.0 pp |
| 2023 | 12.4% | $-42.81 Million | $-346.30 Million | $233.29 Million | $276.10 Million | ▼ -103.4 pp |
| 2022 | 115.7% | $755.10 Million | $652.38 Million | $780.63 Million | $25.52 Million | ▲ +19.4 pp |
| 2021 | 96.3% | $583.53 Million | $605.91 Million | $745.23 Million | $161.70 Million | ▼ -643.9 pp |
| 2020 | 740.2% | $463.67 Million | $62.64 Million | $495.84 Million | $32.17 Million | ▲ +1025.4 pp |
| 2019 | -285.2% | $265.92 Million | $-93.25 Million | $306.85 Million | $40.93 Million | ▼ -210.4 pp |
| 2018 | -74.8% | $146.91 Million | $-196.37 Million | $266.44 Million | $119.52 Million | ▼ -2568.4 pp |
| 2017 | 2493.6% | $245.57 Million | $9.85 Million | $311.60 Million | $66.03 Million | ▲ +2060.3 pp |
| 2016 | 433.3% | $289.05 Million | $66.72 Million | $380.18 Million | $91.13 Million | ▼ -12.2 pp |
| 2015 | 445.5% | $423.74 Million | $95.12 Million | $500.20 Million | $76.47 Million | ▲ +186.6 pp |
| 2014 | 258.8% | $229.19 Million | $88.55 Million | $289.73 Million | $60.54 Million | ▼ -233.2 pp |
| 2013 | 492.1% | $188.09 Million | $38.23 Million | $229.13 Million | $41.04 Million | ▲ +402.2 pp |
| 2012 | 89.9% | $129.50 Million | $144.05 Million | $184.44 Million | $54.94 Million | ▼ -3.3 pp |
| 2011 | 93.2% | $102.43 Million | $109.86 Million | $167.57 Million | $65.13 Million | ▼ -28.8 pp |
| 2010 | 122.0% | $194.65 Million | $159.55 Million | $259.07 Million | $64.43 Million | ▲ +147.1 pp |
| 2009 | -25.1% | $75.01 Million | $-298.34 Million | $131.45 Million | $56.44 Million | ▲ +4.8 pp |
| 2008 | -29.9% | $68.93 Million | $-230.41 Million | $108.09 Million | $39.15 Million | ▲ +20.1 pp |
| 2007 | -50.0% | $89.24 Million | $-178.37 Million | $119.17 Million | $29.93 Million | — |